• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Unexpected viral relapses in hepatitis C virus-infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals.

作者信息

Soria Alessandro, Fabbiani Massimiliano, Lapadula Giuseppe, Gori Andrea

机构信息

Clinic of Infectious Diseases, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.

出版信息

Hepatology. 2017 Sep;66(3):992-994. doi: 10.1002/hep.29181. Epub 2017 Jul 18.

DOI:10.1002/hep.29181
PMID:28370176
Abstract
摘要

相似文献

1
Unexpected viral relapses in hepatitis C virus-infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals.在接受直接抗病毒药物治疗期间被诊断为肝细胞癌的丙型肝炎病毒感染患者中出现的意外病毒复发。
Hepatology. 2017 Sep;66(3):992-994. doi: 10.1002/hep.29181. Epub 2017 Jul 18.
2
Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C.直接作用抗病毒疗法可降低丙型肝炎肝硬化患者肝癌复发率。
Liver Int. 2017 Aug;37(8):1122-1127. doi: 10.1111/liv.13456. Epub 2017 May 25.
3
Things fall apart with hepatocellular carcinoma and direct-acting antivirals.肝细胞癌和直接作用抗病毒药物会导致病情恶化。
Expert Opin Drug Saf. 2018 Feb;17(2):107-109. doi: 10.1080/14740338.2018.1404026. Epub 2017 Nov 14.
4
Secondary prophylaxis of hepatocellular carcinoma: the comparison of direct-acting antivirals with pegylated interferon and untreated cohort.肝细胞癌的二级预防：直接抗病毒药物与聚乙二醇干扰素及未治疗队列的比较
J Viral Hepat. 2017 Jan;24(1):13-16. doi: 10.1111/jvh.12651. Epub 2016 Dec 1.
5
Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?我们是否应该在治疗肝癌的同时治愈丙型肝炎病毒？
Liver Int. 2018 Dec;38(12):2108-2116. doi: 10.1111/liv.13918. Epub 2018 Jul 21.
6
Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study.直接抗病毒药物治疗后肝细胞癌复发：一项欧洲多中心研究。
J Hepatol. 2017 Oct;67(4):876-878. doi: 10.1016/j.jhep.2017.07.007. Epub 2017 Jul 19.
7
[Risk of hepatocellular carcinoma after hepatitis C virus cure with direct-acting antivirals: the next challenges].[丙型肝炎病毒经直接抗病毒药物治愈后发生肝细胞癌的风险：下一个挑战]
Med Sci (Paris). 2018 May;34(5):391-394. doi: 10.1051/medsci/20183405007. Epub 2018 Jun 13.
8
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?直接作用抗病毒药物在肝细胞癌中的反应：肝细胞癌的存在是否重要？
Clin Mol Hepatol. 2019 Jun;25(2):168-171. doi: 10.3350/cmh.2018.1014. Epub 2019 Feb 11.
9
Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C.慢性丙型肝炎直接抗病毒治疗后快速进展的肝细胞癌
Clin J Gastroenterol. 2018 Feb;11(1):69-74. doi: 10.1007/s12328-017-0789-1. Epub 2017 Oct 29.
10
Summaries for patients. Interferon therapy improves survival in patients with liver cancer and hepatitis C virus infection.
Ann Intern Med. 2003 Feb 18;138(4):I52. doi: 10.7326/0003-4819-138-4-200302180-00003.

引用本文的文献

1
Independent Risk Factors for Hepatocellular Carcinoma Recurrence after Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C.直接抗病毒治疗后慢性丙型肝炎患者肝细胞癌复发的独立危险因素。
Gut Liver. 2021 May 15;15(3):410-419. doi: 10.5009/gnl20151.
2
Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study.直接作用抗病毒药物治疗慢性丙型肝炎和肝细胞癌患者的疗效是否相同？一项前瞻性队列研究。
BMJ Open. 2019 May 5;9(5):e026703. doi: 10.1136/bmjopen-2018-026703.
3
Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
直接作用抗病毒药物在肝细胞癌中的反应：肝细胞癌的存在是否重要？
Clin Mol Hepatol. 2019 Jun;25(2):168-171. doi: 10.3350/cmh.2018.1014. Epub 2019 Feb 11.